BeyondSpring Inc.: insider trading
64 trades by 6 directors, officers and 10% owners since 2025, from their SEC Form 4 and 5 filings.
This company files with the SEC as a foreign issuer; its insiders often report prices in the home currency, so amounts are as filed and not converted to dollars.
Bought, 12 months
0
0 purchases by 0 insiders
Sold, 12 months
0
0 sales by 0 insiders
Bought, 3 months
0
0 purchases
Sold, 3 months
0
0 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (6)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Lan HuangChief Executive Officer, Director, 10% owner | — | — | — | |
| Decheng Capital China Life Sciences USD Fund II, L.P.10% owner | — | — | — | |
| Decheng Capital Global Healthcare GP, LLC10% owner | — | — | — | |
| Decheng Capital Management III (Cayman), LLC10% owner | — | — | — | |
| Xiangmin Cui10% owner | — | — | — | |
| Decheng Capital Global Healthcare Fund (Master), LP10% owner | — | — | — |
Trades#
No trades of this kind.
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice